| Dr John E Danneberger, MD | |
|
600 Ridgely Ave Ste 222, Annapolis, MD 21401-1073 | |
| (410) 266-8049 | |
| (410) 266-8054 |
| Full Name | Dr John E Danneberger |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 42 Years |
| Location | 600 Ridgely Ave Ste 222, Annapolis, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982608782 | NPI | - | NPPES |
| 547861800 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | D0038324 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Anne Arundel Medical Center | Annapolis, MD | Hospital |
| Johns Hopkins Hospital, The | Baltimore, MD | Hospital |
| Umd Shore Medical Center At Easton | Easton, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anne Arundel Urology, Pa | 9032178918 | 24 |
| Anne Arundel Urology, Pa | 9032178918 | 24 |
News Archive
Femara showed reduced risk of death by 13% (P=0.08) versus tamoxifen, despite inclusion of patients who had switched over from tamoxifen to Femara during the study period, following the study's unblinding.
Alnylam Pharmaceuticals a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTRsc, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR).
The University of Rhode Island's College of Pharmacy is pairing home visits from pharmacists with the latest technology, providing instant access to a patient's medical history and medications, all in an effort to reduce hospital readmissions.
Fat removed from the lower abdomen and inner thigh through liposuction was found to be an excellent source of stem cells, with higher stem cell concentrations than other areas of the body, reports a Brazilian-based study in August's Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
› Verified 5 days ago
| Entity Name | Anne Arundel Urology, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730365396 PECOS PAC ID: 9032178918 Enrollment ID: O20070817000215 |
News Archive
Femara showed reduced risk of death by 13% (P=0.08) versus tamoxifen, despite inclusion of patients who had switched over from tamoxifen to Femara during the study period, following the study's unblinding.
Alnylam Pharmaceuticals a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTRsc, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR).
The University of Rhode Island's College of Pharmacy is pairing home visits from pharmacists with the latest technology, providing instant access to a patient's medical history and medications, all in an effort to reduce hospital readmissions.
Fat removed from the lower abdomen and inner thigh through liposuction was found to be an excellent source of stem cells, with higher stem cell concentrations than other areas of the body, reports a Brazilian-based study in August's Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John E Danneberger, MD 600 Ridgely Ave Ste 210, Annapolis, MD 21401-1086 Ph: (410) 266-8049 | Dr John E Danneberger, MD 600 Ridgely Ave Ste 222, Annapolis, MD 21401-1073 Ph: (410) 266-8049 |
News Archive
Femara showed reduced risk of death by 13% (P=0.08) versus tamoxifen, despite inclusion of patients who had switched over from tamoxifen to Femara during the study period, following the study's unblinding.
Alnylam Pharmaceuticals a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTRsc, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR).
The University of Rhode Island's College of Pharmacy is pairing home visits from pharmacists with the latest technology, providing instant access to a patient's medical history and medications, all in an effort to reduce hospital readmissions.
Fat removed from the lower abdomen and inner thigh through liposuction was found to be an excellent source of stem cells, with higher stem cell concentrations than other areas of the body, reports a Brazilian-based study in August's Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
› Verified 5 days ago
Shaoqing Zhou, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 600 Ridgely Ave, Annapolis, MD 21401 Phone: 410-266-8049 Fax: 804-828-0191 | |
Dr. Michael J Biles, M.D. Urology Medicare: Medicare Enrolled Practice Location: 600 Ridgely Ave Ste 210, Annapolis, MD 21401 Phone: 410-266-8049 Fax: 410-266-8054 | |
Dr. Jackson Estes Fowler Jr., M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1307 Beachview Rd, Annapolis, MD 21403 Phone: 410-268-1757 | |
Kevin Mcgeagh, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 600 Ridgely Ave Ste 130, Annapolis, MD 21401 Phone: 104-266-8049 Fax: 410-266-8054 | |
Dr. Matthew Gregory Heavner, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 600 Ridgely Ave Ste 222, Annapolis, MD 21401 Phone: 410-266-8049 Fax: 410-266-8054 | |
Robert S Hanley Jr., M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 600 Ridgely Ave, Suite 130, Annapolis, MD 21401 Phone: 410-266-8049 Fax: 410-266-8054 | |
Dr. Ronald Kretkowski, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2973 Southaven Dr, Annapolis, MD 21401 Phone: 410-266-8893 |